News
Helsinn attends 4th Annual Sino-Swiss Business Awards
La RSI in visita presso alcune aziende industriali del nostro territorio
Helsinn to co-host alongside Recordati Rare Diseases satellite symposium on MF-CTCL diagnosis optimization at European Academy of Dermatology and Venereology Congress 2019
Comunicato stampa “Farma Industria Ticino and Credit Suisse Award for best student”, mercoledì 18 settembre 2019
Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma (MF-CTCL) treatment at the 49th European Society for Dermatological Research Annual Meeting 2019
Helsinn and Lyfebulb Announce Call for Applications for Third Annual Patient-Driven Innovation Summit & Award in Oncology
Augusto Mitidieri awarded as “Most Innovative Pharmaceutical CEO – Europe 2019”
Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA’s approval of the oral formulation of Akynzeo® in China
APR presents new data at SSIEM Annual Symposium showing benefits of PKU GOLIKE® in PKU management
Coronavirus
Progetto Talenti
Cultura e salute
Linkedin